Herbal terpenoids activate autophagy and mitophagy through modulation of bioenergetics and protect from metabolic stress, sarcopenia and epigenetic aging
- PMID: 40993327
- DOI: 10.1038/s43587-025-00957-4
Herbal terpenoids activate autophagy and mitophagy through modulation of bioenergetics and protect from metabolic stress, sarcopenia and epigenetic aging
Abstract
Small molecular food components contribute to the health benefits of diets rich in fruits, vegetables, herbs and spices. The cellular mechanisms by which noncaloric bioactives promote healthspan are not well understood, limiting their use in disease prevention. Here, we deploy a whole-organism, high-content screen in zebrafish to profile food-derived compounds for activation of autophagy, a cellular quality control mechanism that promotes healthy aging. We identify thymol and carvacrol as activators of autophagy and mitophagy through a transient dampening of the mitochondrial membrane potential. Chemical stabilization of thymol-induced mitochondrial depolarization blocks mitophagy activation, suggesting a mechanism originating from the mitochondrial membrane. Supplementation with thymol prevents excess liver fat accumulation in a mouse model of diet-induced obesity, improves pink-1-dependent heat stress resilience in Caenorhabditis elegans, and slows the decline of skeletal muscle performance while delaying epigenetic aging in SAMP8 mice. Thus, terpenoids from common herbs promote autophagy during aging and metabolic overload, making them attractive molecules for nutrition-based healthspan promotion.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: G.C. is an employee of DSM-Firmenich. G.L., K.M., G.E.J., F.S., M.H., J.L.S.-G., B.J.B., P.L., B.B., A.-L.E., A.Z., J.R., A.H., L.T., S.M., M.C., J.N.F. and P.G. are employees of Nestlé Research, part of Société des Produits Nestlé SA. Patents owned by Société des Produits Nestlé SA have been filed related to this work, and the list of inventors includes authors of this article. Patent application publications can be found using the following identifiers: WO2023165870A1 , WO2024099886A1 and WO2022128870A1 . M.A.Q., D.S.P. and S.A.V. are employees of NemaLife Inc., which has received fees from Nestlé Research for preclinical services. The Regents of the University of California are the sole owners of patents and patent applications directed at epigenetic biomarkers and the mammalian array for which S.H. is a named inventor. S.H. is a founder and paid consultant of the nonprofit Epigenetic Clock Development Foundation, which licenses these patents. No new patents were filed for epigenetic age analysis as part of this study. S.H. is a principal investigator at Altos Labs. R.T.B. is a cofounder and employee of the nonprofit Epigenetic Clock Development Foundation. J.A. is a consultant and/or scientific advisory board member of MitoBridge/Astellas, MetroBiotech, Amazentis, Vandria, OrsoBio and NovMetapharma. The other authors declare no competing interests.
References
-
- GBD 2019 Diseases and Injuries Collaborators.Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396, 1204–1222 (2020). - DOI
Grants and funding
- ERC-AdG-787702/EC | EC Seventh Framework Programm | FP7 Ideas: European Research Council (FP7-IDEAS-ERC - Specific Programme: "Ideas" Implementing the Seventh Framework Programme of the European Community for Research, Technological Development and Demonstration Activities (2007 to 2013))
- SNSF 31003A_179435/Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation)
- CRSII5_202302/Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation)
- 2017K1A1A2013124/National Research Foundation of Korea (NRF)
- GMR23T2152/Fondazione Telethon (Telethon Foundation)
LinkOut - more resources
Full Text Sources